KLOW — Multi-Peptide Research Blend

Research blend combining BPC-157, TB-500, KPV, and GHK-Cu for investigating coordinated cytoprotection, inflammatory signaling, and extracellular matrix remodeling pathways.

KPV Peptide— Research Overview (RUO)

C-terminal tripeptide of α-MSH investigated for melanocortin-independent modulation of inflammatory signaling pathways in epithelial and immune research models.

GLP2-T

2023788-19-2

Thymosin Alpha-1 (TA1)

62304-98-7

Tesamorelin

218949-48-5

Selank

129954-34-3

GLP3-R

2381089-83-2

PT-141

189691-06-3